FOX News – Test aids prostate cancer treatment
Genomic Health Inc. has struck a deal to commercialize a new blood test that can help advanced prostate cancer patients decide whether to try costly new-generation drugs or rely on much cheaper traditional chemotherapy to improve their chances for survival. The test, developed by closely held Epic Sciences Inc., San Diego, detects a mutation associated with a poor response to two new drugs, Xtandi from Medivation Inc. and Astellas Pharma Inc. of Japan, and Zytiga from Johnson & Johnson.

CNN – U.S. has highest car crash death rate, despite progress, CDC says
More people die in car crashes each year in the United States than in other high-income countries, the Centers for Disease Control and Prevention said in a report Wednesday. In 2013, more than 32,000 people died on U.S. roads, roughly 90 fatalities a day, according to the CDC. The U.S. has seen a 31% reduction in its motor vehicle death rate per capita over the past 13 years. But compared with 19 other wealthy countries, which have declined an average of 56% during the same period, the U.S. has the slowest decrease. Road death rates in countries such as Spain and Denmark have dropped 75.1% and 63.5%, respectively.

U.S. News – Study: Insurers’ spending on costly meds soared from 2003-14
The latest study of medicine prices finds U.S. insurers’ spending on expensive prescription drugs nearly quadrupled from 2003 through 2014, when the number of such prescriptions filled tripled. Spending on expensive “specialty” drugs by commercial insurance plans jumped from 11 percent of spending on all prescriptions filled in 2003 to 43 percent in 2014, according to the study, published Wednesday by the journal Health Affairs. Meanwhile, the number of prescriptions for specialty drugs rose from 0.6 percent of prescriptions filled in 2003 to 1.8 percent in 2014. Researcher Stacie Dusetzina, an assistant professor of pharmacy and public health at the University of North Carolina-Chapel Hill, found patients’ out-of-pocket costs for pricey drugs climbed 46 percent over that period.

NPR – After Medical Marijuana Legalized, Medicare Prescriptions Drop For Many Drugs
Prescription drug prices continue to climb, putting the pinch on consumers. Some older Americans appear to be seeking an alternative to mainstream medicines that has become easier to get legally in many parts of the country. Research published Wednesday found that states that legalized medical marijuana — which is sometimes recommended for symptoms like chronic pain, anxiety or depression — saw declines in the number of Medicare prescriptions for drugs used to treat those conditions and a dip in spending by Medicare Part D, which covers the cost on prescription medications.

NBC News – Many Popular Sunscreens Don’t Meet Guidelines, New study Finds
That sunscreen you love might not be the sunscreen you really need. A new study in JAMA Dermatology finds many of the most popular sunscreens sold on Amazon don’t provide proper protection. “There is a gap in consumer knowledge on sunscreen,” Shuai Xu, co-author and a resident in dermatology at the Northwestern University Feinberg School of Medicine, said. To understand what sunscreens people actually use compared to what they need to prevent burning, the researchers looked at the most popular sunscreens on Amazon — the top 1 percent, or 65 products.